Tenaya Therapeutics Inc. (TNYA) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Tenaya Therapeutics Inc. (TNYA)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

1.44

-0.06 (-4.00%)

At close: Jan 14, 2025, 3:59 PM

1.47

2.08%

Pre-market Jan 15, 2025, 06:25 AM EST

undefined% (undefined)

Bid	1.47
Market Cap	114.08M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-1.44
PE Ratio (ttm)	-1
Forward PE	n/a
Analyst	Buy

Ask	1.48
Volume	1,683,758
Avg. Volume (20D)	5,017,749
Open	1.54
Previous Close	1.50
Day's Range	1.44 - 1.55
52-Week Range	0.99 - 7.01
Beta	undefined

About TNYA

Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hypertrophic cardiomyopathy (gHCM) caused by haploinsufficient myosin binding protein C3 (MYBPC3) gene mut...

[Show more]

Industry Biotechnology

Sector Healthcare

IPO Date Jul 30, 2021

Employees 140

Stock Exchange NASDAQ

Ticker Symbol TNYA

Website https://www.tenayatherapeutics.com

Analyst Forecast

According to 4 analyst ratings, the average rating for TNYA stock is "Buy." The 12-month stock price forecast is $18, which is an increase of 1150.00% from the latest price.

Buy 100.00%

Hold 0.00%

Sell 0.00%

Stock Forecasts

Next Earnings Release

Tenaya Therapeutics Inc. is scheduled to release its earnings on Mar 17, 2025, during market hours.
Analysts project revenue of $1.00M, reflecting a n/a YoY growth and earnings per share of -0.4, making a 0.00% YoY.

Why Price Moved

4 weeks ago · Source

-51.04%

Tenaya Therapeutics shares are trading lower. The ... Unlock content with Pro Subscription

1 month ago · Source

+11.15%

Tenaya Therapeutics shares are trading higher after HC Wainwright & Co. reiterated a Buy rating on the stock and announced a price target of $18.

News

4 weeks ago · https://thefly.com

Tenaya Therapeutics price target lowered to $6 from $8 at Leerink

Leerink lowered the firm's price target on Tenaya Therapeutics to $6 from $8 and keeps an Outperform rating on the shares after the company announced initial Phase 1b/2 MyPEAK-1 data for TN-201 in MYB...